How Corneal Ectasia Prediction is Shaping the Future of Treatment

Corneal ectasia remains one of the most feared complications in anterior segment surgery, despite a low reported incidence across literature. 

Whether presenting as keratoconus or emerging years after an otherwise uneventful procedure, its impact on a patient’s life is profound. For decades, our profession has focused on detecting ectasia once it is already visible. 

This approach is now showing its limits.

A growing body of evidence has demonstrated that many patients who go on to develop post-surgical ectasia appeared clinically normal at the time of treatment. Standard topography, central pachymetry and threshold-based exclusion criteria were often satisfied, yet biomechanical failure still occurred. 

This disconnect has forced a fundamental rethink of how risk is assessed and why prediction, not detection, must now sit at the centre of ectasia management.

Why traditional screening is no longer enough

Classic ectasia screening evolved in an era when the tools available primarily described corneal shape. Placido disc topography and later Scheimpflug tomography allowed clinicians to identify asymmetric curvature, inferior steepening and abnormal thickness distribution while anterior segment OCT added increasingly detailed information about corneal structure and thickness. These advances were transformative, but they also created a false sense of security.

Refractive surgery has exposed the shortcomings of morphology-only screening. Numerous reports have shown that post-LASIK ectasia often arises in corneas that fell within accepted preoperative limits. 

The problem is not that clinicians failed to read the maps correctly. It is that maps alone do not describe how a cornea will behave once its load-bearing capacity has been altered.

Shape is a consequence of structure, not a substitute for it. A cornea can look regular and still be biomechanically fragile. Conversely, mild topographic irregularity does not always imply instability. This is why modern best practices are embracing a combination of tomography and biomechanical analysis.

It’s time to view corneal ectasia as a biomechanical failure

At its core, ectasia represents a loss of structural integrity. The cornea’s viscoelastic tissue is designed to maintain shape under constant intraocular pressure and external forces. When this balance is disrupted, progressive deformation follows.

Two corneas with similar curvature and thickness can respond very differently to the same surgery. Factors such as collagen, interlamellar cohesion and regional stiffness determine how load is distributed and how deformation spreads over time. These properties are invisible to static imaging.

This is why ectasia cannot be fully understood as a geometric problem. Thickness and curvature describe what the cornea looks like. They do not explain how it deforms, how quickly it yields under stress or how effectively it recovers. Biomechanics fills that gap by characterising tissue behaviour rather than appearance.

This means that we need to shift from detection to prediction

For decades, ectasia management has centred around binary screening. We’re now seeing a shift to probability-based risk estimation.

Instead of asking whether an eye has ectasia, the more relevant question is how likely it is to become unstable, particularly in the context of a proposed intervention.

Patient factors such as age and refraction must be considered alongside surgical variables, including ablation depth or flap design. The most important thing to note? No single parameter is decisive.

Structure, material properties and load all play an important role in the likelihood of developing ectasia. Prediction acknowledges inherent uncertainty and manages it, rather than masking it behind pass or fail labels. In addition to this, AI tools are helping us build predictive models, making diagnoses faster and more consistent. 

Tomography and biomechanics are complementary tools

Modern pre-emptive risk assessment integrates two key domains:

Tomographic data captures anterior and posterior curvature, pachymetric progression and spatial thickness distribution. The OCULUS Pentacam is the gold standard in anterior segment tomography and is becoming commonplace in clinics screening for Ectasia. 

Biomechanical assessment evaluates deformation amplitude, applanation dynamics and viscoelastic response. The OCULUS Corvis ST is the perfect complement to the Pentacam, allowing for the calculation of a biomechanically corrected IOP (bIOP) and supporting the early detection of ectatic diseases such as keratoconus.

Scheimpflug tomography remains foundational in ectasia assessment. Devices such as the Pentacam have refined our ability to visualise posterior elevation changes, detect early pachymetric abnormalities and identify subtle spatial patterns that precede clinical disease. Other imaging technologies, such as the Tomey CASIA2 anterior segment OCT, can provide detailed assessment of anterior segment structures and corneal morphology. These insights are incredibly useful, but they’re not necessarily conclusive.

Biomechanical evaluation adds a functional dimension. This is where the Corvis ST shines, as it’s able to assess how the cornea deforms in response to a controlled air pulse by capturing 4,300 images per second. By analysing deformation speed, amplitude and recovery behaviour, clinicians gain insight into tissue stiffness and damping characteristics.

Above: an example of the Corvis ST’s Biomechanical/Tomographic Assessment (TBI)

TBI – the Tomographic Biomechanical Index – Double Down on Your Decision

When combined, tomography and biomechanics offer a more complete picture of corneal stability. 

The Tomographic Biomechanical Index (TBI) assesses the risk of corneal ectasia at a glance. The value is calculated automatically from the measurement data of the Pentacam and the Corvis ST in real time during the analysis.

Combined indices like TBI draw on dual data streams (from both the Pentacam and Corvis ST) to contextualise an individual eye against normative populations and known patterns, effectively grading risk factors for ectasia, meaning surgeons can decide whether laser surgery is the right choice. 

The assessment is automatic, using a simple traffic light system (green, yellow, red) to recognise critical changes before they become clinically visible. 

TBI allows clinicians to:

• Recognise ectasia at an early stage
• Make safer decisions (especially in regards to refractive procedures)
• Save significant time
• Draw on decades of research

This approach has been shown to improve sensitivity when detecting ectasia susceptibility, especially when compared with either modality alone. This is particularly useful in eyes that appear borderline.

TBI v2 is currently available, with TBI v3 on the horizon, bringing with it even higher degrees of specificity and sensitivity.

The role of AI in the early detection of ectasia

Machine learning algorithms are being trained on large datasets, specifically to identify complex patterns that may not be instantly apparent on initial review. 

Its purpose isn’t to replace clinical judgement, but to augment it. 

Supported by AI-driven analysis, the TBI streamlines workflows, improves patient selection, and ultimately increases surgical throughput. It’s a powerful diagnostic combination, designed to help practitioners confidently determine the best refractive surgery approach for every patient.

These AI tools can be used to help catch symptoms earlier, particularly identifying potential for ectasia in children/teenagers, allowing for preventative treatments.

What does the future of corneal ectasia treatment look like?

The future of corneal ectasia treatment lies in a deeper understanding of corneal behaviour; in images that quantify deformation rather than making inferences based on shape. 

Instruments such as the Corvis ST allow clinics to perform modern biomechanical assessments, capturing how the cornea responds to controlled stress with a high-speed Scheimpflug camera. This yields objective measurements of tissue response, stiffness and dynamic behaviour, something that was previously impossible. 

It represents more than another diagnostic tool; it represents both qualitative impressions and quantitative analysis, with outputs that are highly automated, yet rich in interpretive value. 

The bottom line is this:

The OCULUS Corvis ST is changing how clinics around the world approach corneal ectasia. 

Early detection means preventative measures can begin sooner, potentially saving patients’ vision and preventing the need for costly transplant procedures. 

If you’d like to arrange a demo or you’ve got any questions about the device, we’d be happy to help. Get in touch by clicking the button below:

Talk to a specialist